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The United States (US) Census Bureau estimates the current US population at 301 million with elderly
people (>65 years old) accounting for 36 million. Within this group, the fastest growing segment of the
population is >85 years of age, which currently numbers w5 million and is expected to rise to w20
million by 2050. Over the decades there has been speculation that gastrointestinal structure and function
decline with age. Therefore, the physiological changes in the gut with aging and their clinical implica-
tions have become important topics for discussion. This review also attempts to document the role of
probiotics in enhancing gut activity in older persons.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction: the aging intestines
The small intestine does not reveal structural and functional
deteriorations with aging under normal conditions. This is
explained on the basis of increased small bowel enterocyte prolif-
eration and apoptosis in elderly people, which helps maintain the
mucosal architecture.1 Thus, small bowel intestinal histology and
permeability do not appear to change with aging.2 However, the
hyperproliferative state and exaggerated apoptosis can result in
cellular immaturity, which contributes to some impaired absorp-
tive function under conditions of stress in elderly people.
2. Microbiota changes
Commensal intestinal ﬂora plays an important role in the
maintenance of the host health by providing nutrients and a pro-
tective barrier against invading organisms. There are, however,
reports of shifts in the composition of intestinal microbiota with
age, with increased numbers of facultative anaerobes and Gram-
negative bacteria (mainly Enterobacter) and a decrease in the
number of beneﬁcial organisms such as lactobacilli and biﬁdobac-
teria.3 These changes, along with a general reduction in species
diversity inmost bacterial groups, and changes to diet and digestiveity Berwyn, Zip Code 60402,
h).
linical Gerontology & Geriatrics. Pphysiology such as intestinal transit time, may result in increased
putrefaction in the colon and a greater susceptibility to disease and
infection.4 Besides, thesemicrobiota changes are believed to induce
a subclinical intestinal inﬂammation in elderly people, leading to a
low systemic inﬂammatory status and chronic disease in this
population.5
2.1. Small bowel bacterial overgrowth
Small bowel bacterial overgrowth (SBBO), deﬁned by an
abnormal increase in the number of bacteria in the small intestine,
is found in elderly people. SBBO has been associated with nutrient
malabsorption and diarrhea, which lead tomalnutrition andweight
loss in elderly people. Various trials using antibiotics to decrease
SBBO in older persons have led to improved anthropometric and
nutritional measurements, further cementing the role of SBBO in
malabsorption and its consequences with aging.6e10 Clinically
nonapparent SBBO and few mucosal changes may be important
causes of lactose malabsorption in elderly people.11
2.2. Carcinogenic transformation
Age-associated enterocyte hyperproliferation and decreased
apoptosis in the colon have been implicated as potential causes of
carcinogenic transformation in elderly people.12 This can partly be
explained by increased activity of epithelial growth factor receptor
(EGFR) and its family members, which in turn may be due toublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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tein.13 In addition, depleted levels of cell-cycle and apoptosis
regulator protein-1, a novel protein associated with apoptosis
signaled by EGFR, are seen with aging in the colonic mucosa.14
2.3. Nutrient absorption
Malabsorption of carbohydrates, lipids, amino acids, minerals,
and vitamins has been described in elderly people. Elderly people
are also at risk for malnutrition due to poor dentition or decaying
teeth and dysphagia that may interfere with eating, loss of smell or
taste sensations, chronic illnesses that interfere with digestion or
absorption of food, and increased nutritional requirements. Other
factors such as medication side effects; depression; social isolation;
functional, visual, and cognitive impairment; and economic bar-
riers to obtaining high-quality foods all can lead to malnutrition.15
The ability of the intestine to adapt may be impaired in elderly
people and this may lead to further malnutrition.16 Of particular
concern is reduced calcium absorption in elderly people. This
decrease could be due to a decline in either the active calcium
transport or diffusion component of the calcium absorption sys-
tem.17 Furthermore, there have been reports of decreased numbers
of enterocyte vitamin D receptors and reduced intestinal respon-
siveness to the action of 1,25-dihydroxyvitamin D3. This defect
could lead to compensatory increases in parathyroid hormone
secretion and 1,25-dihydroxyvitamin D3 production, which main-
tains calcium absorption and serum ionic calcium, but at the
expense of increased bone loss.18,19
2.4. Neurodegeneration of the gastrointestinal tract with aging
Aging is associated with degeneration of the enteric nervous
system with the loss of neurons in both the submucosal and
myentric plexuses. This process seems to affect selectively the
cholinergic neurons and interstitial cells of Cajal with inhibitory n1
(including nitrergic) neurons being spared. The enteric glia is also
depleted with the distal gut most severely affected, and this may be
responsible for age-related functional problems of constipation,
incontinence, and evacuation.20e24
2.5. Immune function in elderly people
Aging affects both the innate and adaptive immune responses.
There is a decrease in phagocytosis, alteration of cellular migration,
changes in cell populations and numbers, and decreased antibody
production. It has been reported that gut microbial ﬂora have a
signiﬁcant effect on the host immune system and can lead to
autoimmune-related disease such as rheumatoid arthritis, inﬂam-
matory bowel diseases, and type I diabetes if microbial ﬂora are
altered as in overuse of antibiotics.25
3. Probiotics, prebiotics, and synbiotics: Fountain of life?
Probiotics are deﬁned as viable microorganisms; sufﬁcient
amounts of which reach the intestine in an active state and thus
exert positive health effects. Numerous probiotic microorganisms
(e.g., Lactobacillus rhamnosus GG, Lactobacillus reuteri, biﬁdobac-
teria, and certain strains of Lactobacillus casei or the Lactobacillus
acidophilus group) are used in probiotic food. A prebiotic is “a
selectively fermented ingredient that allows speciﬁc changes, both
in the composition and/or activity in the gastrointestinal microﬂora
that confers beneﬁts upon the host’s well being and health”. Inulin-
type fructans, selective fermentable chicory fructans, are the major
prebiotics used and synergistic combinations of probiotics and
prebiotics are called synbiotics.3.1. Immunomodulatory effects of probiotics
Aging is associated with immunosenescence characterized by
depleted cellular immunity, which may predispose to increased
risk of infections in elderly people. Probiotic supplementation has
been demonstrated to increase natural killer cell and phagocytic
activity, with the maximum beneﬁt being in the elderly popula-
tion.26e28 Moreover, probiotics may ameliorate the detrimental
effects of malnutrition on immunity in elderly people by improving
the nutritional and immune status, as demonstrated by increasing
levels of serum albumin and intestinal immunoglobulinA (IgA)
production (seen in trials on aged mice).29e31
3.2. Changes in intestinal microbiota with prebiotics and probiotics
and the clinical implications
Probiotic and synbiotic administration have been documented
to increase intestinal levels of beneﬁcial lactobacilli, biﬁdobacteria,
and enterocooci, with reduced levels of enterobacter. This may well
counter the age-related changes in the intestinal microbiota and
therefore reduce the risk of infections.32,33 An interesting effect of
probiotics may be a reduction in Clostridium-difﬁcile-associated
diarrhea; one of the most common nosocomial infection in aged
individuals.3,34 A study has shown that administration of prebiotics
also results in increased numbers of beneﬁcial intestinal ﬂora
(especially biﬁdobacteria), increased anti-inﬂammatory cytokines,
and decreased proinﬂammatory cytokines, which result in a
decrease in overall gut inﬂammation in elderly people.35,36
3.3. Inhibition of carcinogenesis
Prebiotic and synbiotic administration is believed to stimulate
the growth of beneﬁcial biﬁdobacteria and lactobacilli in the in-
testine.37 They have been demonstrated to inhibit the develop-
ment of aberrant crypt foci in the colonic mucosa, suggesting the
tumor-inhibiting properties of chicory fructans. Animal trials
have also shown reduced colonic mucosal proliferation and
decreased activities of colonic mucosa and tumor ornithine
decarboxylase and ras-p21.38,39 Prebiotics via their interaction
with gut ﬂora give fermentation products, and these short chain
fatty acids (butyrate and propionate) inhibit growth of colon tu-
mor cells and histone deacetylases. Butyrate also causes apoptosis,
reduces metastasis in colon cell lines, and protects the body from
genotoxic carcinogens by enhancing expression of enzymes
involved in detoxiﬁcation.40e42
3.4. Prebiotics, probiotics, synbiotics, and nutrient absorption
Prebiotics/synbiotics have been demonstrated to increase min-
eral absorption, particularly that of calcium and magnesium.43,44
The underlying mechanisms are manifold: increased solubility of
minerals because of increased bacterial production of short-chain
fatty acids, which is promoted by the greater supply of substrate;
an enlargement of the absorption surface by promoting prolifera-
tion of enterocytes mediated by bacterial fermentation products,
predominantly lactate and butyrate; increased expression of
calcium-binding proteins; improvement of gut health; degradation
of mineral complexing phytic acid; release of bone-modulating
factors such as phytoestrogens from foods; and stabilization of
the intestinal ﬂora and ecology.45 Increased calcium absorption
would therefore make inulin-type fructans, promising substances
that could help to improve the supply with available calcium in
human nutrition, thus contributing to bone health.46e49 Supple-
mentation of probiotics and yogurt inﬂuence the colonic bacteria,
and increase the number of main groups of colonic microﬂora,
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alleviating lactose intolerance symptoms.48
4. Conclusion
The gastrointestinal tract has a complex community of micro-
biota that provides beneﬁts to its host in many different ways,
including detoxiﬁcation, nutrient production, drug metabolism,
protection against pathogens, and regulation of the immune system.
Animal and/or human studies have demonstrated that changes in
these gut microbial communities can cause immune dysregulation
and there are data that support the use of probiotics in antibiotic-
associated colitis, ulcerative colitis, irritable bowel disease, pou-
chitis, and radiation-induced enteritis. More intriguing is the role of
probiotics in nongastrointestinal disorders, such as obesity, diabetes
mellitus, and metabolic syndrome. The future of using genetically
modiﬁed microorganisms to provide epitopes for vaccine delivery
to improve the immune response is also being researched. Of note is
the recent use of fecal transplants to protect against C. difﬁcile, ir-
ritable bowel disease, and even to counter the metabolic syndrome
by increasing insulin sensitivity in the latter; an exciting area for
research. Finally, can synbiotics serve as implantable biologic
pacemakers? Animal studies have shown that synbiotics increase
the myoelectric activity of the small intestine and colon and may
help reverse age-related intestinal motility decay, and therefore
reduce the incidence of functional disorders such as constipation
seen in elderly people. Although a case can be made for progression
from health to disease with gut alteration of microbiota ratios with
aging, reversal of disease in response to correction of these ratios is
unclear at this time and a subject for future research.
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